Acute effects of liraglutides on gene expression in the hearts of mice with experimental myocardial infarction

Glucagon-like peptide-1 receptor (GLP-1R) agonists reduce the rates of major cardiovascular events, including myocardial infarction in people with type 2 diabetes, and decrease infarct size while preserving ventricular function in preclinical studies. Nevertheless, the precise cellular sites of GLP-1R expression that mediate the cardioprotective actions of GLP-1 in the setting of ischemic cardiac injury are uncertain. Here, cardiac gene expression profiles regulated by liraglutide were examined using RNA-Seq to interrogate mouse atria and both non-infarcted and non-infarcted ventricular tissue after acute coronary artery ligation. Overall design: Bulk RNA-seq was performed on the atria, and non-infarcted and infarcted regions of the left ventricle isolated from mice with experimental myocardial infarction.